At first reading, my reaction was maybe
the studies arrived at conclusions not looked for and maybe were not
news or worthy of publication. With many studies that do make the
press and even some that do make the journals being highly suspect,
we do need to be aware that many more studies never see print because
of poor results. Are our researchers so agenda driven that when a
study does not obtain the desired results, they bury the results.
These are just a few of the questions
that need to be asked. These studies were funded by taxpayer dollars
and therefore should be published. Even if they are not news or
worthy of publication, there are alternative methods for providing
timely public access to study results, including the results database
at Clinical Trials.gov that was created in response to Federal law.
The study, which appears in the January
issue of the British Medical Journal, states that less than one-half
of the trials funded fully or in part by the National Institutes of
Health were published within 30 months of completion and that
one-third of trials remained unpublished 51 months after completion.
This is a very poor return on investment and if the results were
actually unworthy of publication indicates that approval needs to be
reviewed to prevent poorly premised studies from being funded.
Science Daily again published their second report on January 5 on the same study and this report is more
telling in the lack of reporting the their article of January 3.
“They found that out of 738 trials that
were classified as subject to mandatory reporting, just 163 (22 per
cent) had reported results. The study found that the influence of the
funding body or sponsor seemed to be considerable -- industry funded
trials subject to mandatory reporting were far more likely to report
results compared with other funders. Importantly a positive effect of
the legislation was noted -- where trials did not fall under the
legislation only 10 per cent of them had reported results.”
Another argument voiced in the press
release says that when research findings are not disseminated, the
scientific process is disrupted and allows redundant studies to be
funded. Not only does this permit a waste of funds available for
research of many pressing studies, but also it has far-reaching
effects for policy decisions and even institutional review board
assessments of risks and benefits associated with future research
studies.
We all know that non-publication and
delayed publication (and even burying of results) happens for studies
and trials funded by the pharmaceutical and medical device
industries, as well as by non-profit organizations. While the
authors state more work needs to be done to understand the problems
leading to publication, no mention is made of why poorly designed
studies are allowed to be funded in the first place and the results
buried when the researchers arrive at conclusions other than what
they wanted. A procedure for determining who receives funding also
needs a thorough review.
Then January 4, 2012 from the NIH makes
this announcement “National Institute of General Medical Sciences
reorganizes.” Make one wonder if they are taking this study
seriously. This is highly doubtful as is clearly stated here, “The
amount of money allocated to programs in the new divisions will not
change as a result of the reorganization or transfer of NCRR
programs. Most grants in the new divisions will continue to be
managed by the same staff members.”
Will we see changes in publishing of
studies? Highly doubtful! Just more layers of governmental
bureaucracy.